Tonix Pharmaceuticals Holding Corp (TNXP) support and resistance · rev $20.4M
Tonix Pharmaceuticals Holding Corp (TNXP) is a biotechnology company listed on NASDAQ.
This page maps Tonix Pharmaceuticals Holding Corp (TNXP) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported TNXP revenue for 2026-06-30 was $20.4M. Net income was -$80.7M. TNXP currently screens at market cap $194.5M.
TNXP currently screens at market cap $194.5M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new TNXP 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the TNXP quote page for the session range and the stock page for the full model.
Not investment advice.